Related Experiment Videos
Effects of interferon-alpha2b on hearing
Irfan Kaygusuz1, Türkkan Oztürk Kaygusuz, Ahmet Oztürk
1Department of Otorhinolaryngology, Medical Faculty, Firat University, Elaziğ, Turkey. kaygusuz_67@yahoo.com
International Journal of Audiology
|January 13, 2005
Summary
Interferon-alpha2b treatment for chronic active hepatitis B showed no significant negative effects on patient hearing. Further research with larger patient groups is recommended to confirm the safety of this therapy regarding auditory health.
Area of Science:
- Hepatology
- Otolaryngology
- Pharmacology
Background:
- Chronic active hepatitis B is a significant global health concern.
- Interferon-alpha2b is a common treatment for hepatitis B.
- Potential side effects of interferon therapy, including ototoxicity, require investigation.
Purpose of the Study:
- To evaluate the impact of interferon-alpha2b on hearing thresholds in patients with chronic active hepatitis B.
- To determine if interferon-alpha2b treatment affects auditory function.
Main Methods:
- A cohort of 26 patients with chronic active hepatitis B was recruited.
- Pure-tone audiometry was used to assess hearing thresholds.
- Hearing was evaluated before and after 6 months of interferon-alpha2b treatment.
Main Results:
- No statistically significant changes in hearing thresholds were observed after 6 months of interferon-alpha2b treatment (p>0.05).
- The data suggests that interferon-alpha2b does not adversely affect hearing in this patient group.
Conclusions:
- Interferon-alpha2b therapy appears to be safe concerning hearing function in patients with chronic active hepatitis B.
- Larger-scale studies are necessary to definitively establish the ototoxic safety profile of interferon-alpha2b for hepatitis B patients.